Paul E. Freiman - 11 May 2022 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
Director
Signature
/s/ Justin Hall as attorney in fact for Paul E. Freiman
Issuer symbol
NBY
Transactions as of
11 May 2022
Net transactions value
$0
Form type
4
Filing time
13 May 2022, 20:31:24 UTC
Previous filing
25 May 2021
Next filing
24 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBY Restricted Stock Units Award $0 +30,000 $0.000000 30,000 11 May 2022 Common Stock 30,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.